Product NDC: | 54575-972 |
Proprietary Name: | BLACK WILLOW POLLEN |
Non Proprietary Name: | salix nigra pollen |
Active Ingredient(s): | 1 g/20mL & nbsp; salix nigra pollen |
Administration Route(s): | PERCUTANEOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54575-972 |
Labeler Name: | Allergy Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA101376 |
Marketing Category: | BLA |
Start Marketing Date: | 19671207 |
Package NDC: | 54575-972-30 |
Package Description: | 30 mL in 1 VIAL, MULTI-DOSE (54575-972-30) |
NDC Code | 54575-972-30 |
Proprietary Name | BLACK WILLOW POLLEN |
Package Description | 30 mL in 1 VIAL, MULTI-DOSE (54575-972-30) |
Product NDC | 54575-972 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | salix nigra pollen |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | PERCUTANEOUS; SUBCUTANEOUS |
Start Marketing Date | 19671207 |
Marketing Category Name | BLA |
Labeler Name | Allergy Laboratories, Inc. |
Substance Name | SALIX NIGRA POLLEN |
Strength Number | 1 |
Strength Unit | g/20mL |
Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |